Hofnar schreef op 15 juni 2017 10:33:
[...]Bedankt voor het posten van dit rapport!
During our research, we identified 76 NIPTs; of the commercially available tests, majority are laboratory-developed tests while
only a few are CE-IVD certified. The CE-IVD marked tests include Clarigo® (Multiplicom), Harmony® test (Ariosa Diagnostics, acquired by Roche), IONA® test (Premaitha Health), Prenatal BACs-on-BeadsTM (PerkinElmer®), PraenaTest® / PrenaTest® (LifeCodexx, a subsidiary of GATC Biotech), Prendia (Genesupport, FASTERIS, Swiss Institute for Bioinformatics), SerenityTM test (Genesis GeneticsTM) and
Tranquility (Genoma, a subsidiary of ESPERITE).Naast betere communicatie naar aandeelhouders kan de communicatie naar de markt ook nog wel wat aandacht gebruiken (maar dat gaat vast goed komen met recente investeringen in sales/marketing).